STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
12 Months Ended |
Mar. 31, 2019 |
Sep. 30, 2018 |
| Equity [Abstract] |
|
|
| Schedule of assumptions used to calculate the fair value of warrants issued on grant date |
|
The
following assumptions were used to calculate the fair value of the Company’s warrants issued as stock based compensation
on the date of grant:
| |
|
Year
Ended September 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Expected
term |
|
|
1.59 to 2 years |
|
|
|
— |
|
| Expected
volatility |
|
|
73% - 161 |
% |
|
|
— |
|
| Expected
dividends |
|
|
0 |
% |
|
|
— |
|
| Risk-free
rates |
|
|
1.73% - 2.42 |
% |
|
|
— |
|
|
| Schedule of warrants issued and outstanding |
Below
is a table summarizing the warrants issued and outstanding as of March 31, 2019 (“Price” reflects the weighted average
exercise price per share):
| |
|
Warrants |
|
|
Price |
|
| Outstanding at September
30, 2018 |
|
|
805,968 |
|
|
$ |
24.39 |
|
| Granted |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
— |
|
|
|
— |
|
| Forfeited or expired |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
(1,028 |
) |
|
|
157.60 |
|
| Outstanding at March
31, 2019 |
|
|
804,940 |
|
|
$ |
24.22 |
|
| Exercisable at
March 31, 2019 |
|
|
804,940 |
|
|
$ |
24.22 |
|
|
Below
is a table summarizing the warrants issued and outstanding as of September 30, 2018 and 2017:
| |
|
Warrants |
|
|
Price |
|
| Outstanding
at September 30, 2016 |
|
|
30,810 |
|
|
$ |
101.60 |
|
| Granted |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
1,000,128 |
|
|
|
31.20 |
|
| Stock-based
compensation warrants |
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
— |
|
|
|
— |
|
| Forfeited
or expired |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
(210,667 |
) |
|
|
60.60 |
|
| Stock-based
compensation warrants |
|
|
(11,303 |
) |
|
|
147.40 |
|
| Outstanding
at September 30, 2017 |
|
|
808,968 |
|
|
$ |
24.60 |
|
| Granted |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
12,500 |
|
|
|
20.00 |
|
| Exercised |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
(13,500 |
) |
|
|
20.00 |
|
| Stock-based
compensation warrants |
|
|
— |
|
|
|
— |
|
| Forfeited
or expired |
|
|
|
|
|
|
|
|
| Investor
warrants |
|
|
— |
|
|
|
— |
|
| Stock-based
compensation warrants |
|
|
(2,000 |
) |
|
|
86.40 |
|
| Outstanding
at September 30, 2018 |
|
|
805,968 |
|
|
$ |
24.39 |
|
| Exercisable
at September 30, 2018 |
|
|
805,968 |
|
|
$ |
24.39 |
|
|
| Schedule of assumptions used to calculate the fair value of options issued on grant date |
|
The following assumptions
were used to calculate the fair value of the Company’s options on the date of grant:
| |
|
Year Ended September 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Expected term |
|
3.25-5 years |
|
|
5.75 years |
|
| Expected volatility |
|
|
101 |
% |
|
|
91 |
% |
| Expected dividends |
|
|
0 |
% |
|
|
0 |
% |
| Risk-free rates |
|
|
1.68 |
% |
|
|
1.49 |
% |
|
| Schedule of stock option activity |
Below
is a table summarizing the Company’s activity for the six month period ended March 31, 2019 (“Price” reflects
the weighted average exercise price per share):
| |
|
Options |
|
|
Price |
|
| Outstanding
at September 30, 2018 |
|
|
156,625 |
|
|
$ |
57.86 |
|
| Granted |
|
|
— |
|
|
$ |
— |
|
| Exercised |
|
|
— |
|
|
$ |
— |
|
| Forfeited
or expired |
|
|
— |
|
|
$ |
— |
|
| Outstanding
at March 31, 2019 |
|
|
156,625 |
|
|
$ |
57.86 |
|
| Exercisable
at March 31, 2019 |
|
|
124,370 |
|
|
$ |
69.40 |
|
|
Below
is a table summarizing the options issued and outstanding as of September 30, 2018 (“Price” reflects the weighted
average exercise price per share):
| |
|
Year
Ended September 30, |
|
| |
|
2018 |
|
|
2017 |
|
| |
|
Options |
|
|
Price |
|
|
Options |
|
|
Price |
|
| Outstanding
October 1 |
|
|
112,525 |
|
|
$ |
111.60 |
|
|
|
142,873 |
|
|
$ |
133.20 |
|
| Granted |
|
|
82,000 |
|
|
$ |
13.40 |
|
|
|
37,500 |
|
|
$ |
13.00 |
|
| Exercised |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Forfeited
or expired |
|
|
(37,900 |
) |
|
$ |
121.00 |
|
|
|
(67,848 |
) |
|
$ |
102.60 |
|
| Outstanding
September 30 |
|
|
156,625 |
|
|
$ |
57.86 |
|
|
|
112,525 |
|
|
$ |
111.60 |
|
| Exercisable
September 30 |
|
|
98,375 |
|
|
$ |
84.20 |
|
|
|
87,762 |
|
|
$ |
120.00 |
|
| Weighted
average fair value per option granted |
|
|
|
|
|
$ |
8.80 |
|
|
|
|
|
|
$ |
9.60 |
|
|
| Schedule of restricted stock activity |
|
Below
is a table summarizing nonvested restricted stock shares as of September 30, 2018, and changes during the years ended
September 30, 2018, and 2017:
| |
|
Shares |
|
Weighted
Average
Grant Date Fair Value |
| Nonvested
at September 30, 2016 |
|
|
|
30,018 |
|
|
$ |
96.00 |
|
| Granted |
|
|
|
— |
|
|
|
— |
|
| Vested |
|
|
|
(15,759 |
) |
|
|
95.80 |
|
| Forfeited |
|
|
|
(750 |
) |
|
|
195.60 |
|
| Nonvested
at September 30, 2017 |
|
|
|
13,509 |
|
|
$ |
90.60 |
|
| Granted |
|
|
|
— |
|
|
|
— |
|
| Vested |
|
|
|
(13,509 |
) |
|
|
90.60 |
|
| Forfeited |
|
|
|
— |
|
|
|
— |
|
| Nonvested
at September 30, 2018 |
|
|
|
— |
|
|
$ |
— |
|
|